295 related articles for article (PubMed ID: 19808740)
1. 'Time is brain' also in multiple sclerosis.
Freedman MS
Mult Scler; 2009 Oct; 15(10):1133-4. PubMed ID: 19808740
[No Abstract] [Full Text] [Related]
2. [Diagnostics and drug therapy of multiple sclerosis].
Suomen Neurologinen Yhdistys ry
Duodecim; 2002; 118(13):1411-23. PubMed ID: 12239889
[No Abstract] [Full Text] [Related]
3. Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis.
Gout O
Ann Neurol; 2008 Jan; 63(1):126; author reply 126-7. PubMed ID: 17702028
[No Abstract] [Full Text] [Related]
4. Pharmacologic management of multiple sclerosis.
Blasier MG
Urol Nurs; 2008 Jun; 28(3):217-9. PubMed ID: 18605517
[No Abstract] [Full Text] [Related]
5. Glatiramer and suspected multiple sclerosis. No proven advantage.
Prescrire Int; 2010 Aug; 19(108):160. PubMed ID: 20941852
[No Abstract] [Full Text] [Related]
6. A practical guide to pediatric multiple sclerosis.
Huppke P; Gärtner J
Neuropediatrics; 2010 Aug; 41(4):157-62. PubMed ID: 21086219
[TBL] [Abstract][Full Text] [Related]
7. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH; Alam JJ; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Whitham RH
Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746
[TBL] [Abstract][Full Text] [Related]
8. Disease-modifying drugs for the early treatment of multiple sclerosis.
Flachenecker P
Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
[TBL] [Abstract][Full Text] [Related]
9. Seeing injectable ms therapies differently: they are more similar than different.
Johnson KP; Fox RJ; Arnold DL
Neurology; 2010 Feb; 74(8):702. PubMed ID: 20177129
[No Abstract] [Full Text] [Related]
10. [Pharmacological treatment of multiple sclerosis].
Myhr KM
Tidsskr Nor Laegeforen; 2010 Mar; 130(5):490-2. PubMed ID: 20224616
[TBL] [Abstract][Full Text] [Related]
11. Coming of age: the use of immunomodulatory therapy in children with multiple sclerosis.
Banwell B; Tremlett H
Neurology; 2005 Mar; 64(5):778-9. PubMed ID: 15753408
[No Abstract] [Full Text] [Related]
12. Translating new insights into treatment optimisation in multiple sclerosis.
Fazekas F; Kieseier BC
J Neurol Sci; 2009 Feb; 277 Suppl 1():S1-2. PubMed ID: 19200857
[No Abstract] [Full Text] [Related]
13. Current therapeutic recommendations in multiple sclerosis.
Berger T
J Neurol Sci; 2009 Dec; 287 Suppl 1():S37-45. PubMed ID: 20106347
[TBL] [Abstract][Full Text] [Related]
14. [Multiple sclerosis].
Offenhäusser M; Martin R
Med Monatsschr Pharm; 1997 Jun; 20(6):149-57. PubMed ID: 9289627
[No Abstract] [Full Text] [Related]
15. Interferon-beta and neuroprotection in multiple sclerosis--facts, hopes and phantasies.
Kieseier BC; Hartung HP
Exp Neurol; 2007 Jan; 203(1):1-4. PubMed ID: 17069803
[No Abstract] [Full Text] [Related]
16. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
Nervenarzt; 1997 Aug; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
[No Abstract] [Full Text] [Related]
17. [Additional indicators of the assessment of efficacy of disease modifying drugs (preliminary results)].
Iakushina TI; Lizhdvoĭ VIu; Vasilenko IA; Andriukhina OM; Kotov SV
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2 Pt 2):61-5. PubMed ID: 23528596
[TBL] [Abstract][Full Text] [Related]
18. Not every patient with multiple sclerosis should be treated at time of diagnosis.
Pittock SJ; Weinshenker BG; Noseworthy JH; Lucchinetti CF; Keegan M; Wingerchuk DM; Carter J; Shuster E; Rodriguez M
Arch Neurol; 2006 Apr; 63(4):611-4. PubMed ID: 16606780
[No Abstract] [Full Text] [Related]
19. Multiple sclerosis. Part 2: ophthalmic issues in MS therapy.
Pula JH; Javed A
Curr Opin Ophthalmol; 2009 Nov; 20(6):476-81. PubMed ID: 19816177
[TBL] [Abstract][Full Text] [Related]
20. Update on MS treatment.
Ryan M
J Am Pharm Assoc (Wash); 1996 Jul; NS36(7):419-20. PubMed ID: 8840740
[No Abstract] [Full Text] [Related]
[Next] [New Search]
